

The APAC Healthcare Licensing Boom: Trends, Structures & Risks for Investors
Out-licensing has become an increasingly important pathway for healthcare companies seeking to commercialise their innovation, access new markets, and maximise value from their pipelines. Across the APAC region, activity has accelerated significantly, particularly in China, where we have seen a sharp increase in both volume and value of cross-border licensing transactions.
Guest speakers Ren Jun Lim and Jonathan Teo from Baker McKenzie Wong & Leow's healthcare practice will join us to explore:
Trends driving licensing activity
What investors should understand about out-licensing arrangements
Common licensing structures and considerations
Potential risks and pitfalls, drawing on real world examples
Designed specifically for healthcare investors, this session will provide a practical introduction to the out-licensing landscape alongside an opportunity to meet and connect with fellow investor peers. Attendance is subject to approval.